| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| SOPHSOPHiA GENETICS S.A. | 350.09M | 5.16 | -5.43 | 4.49% | -102.29% | -123.55% | 0.31 | |
| TEMTempus AI, Inc. | 11.91B | 68.92 | -14.97 | 30.38% | -18.45% | -40.15% | 8.31 | |
| WGSGeneDx Holdings Corp. | 3.16B | 109.28 | -56.33 | 50.79% | 0.52% | 0.71% | 0.47 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Sales/Revenue | 25.36M | 28.4M | 40.45M | 47.56M | 62.37M | 65.17M |
| Revenue Growth % | - | 0.12% | 0.42% | 0.18% | 0.31% | 0.04% |
| Cost of Goods Sold | 7.53M | 10.71M | 15.23M | 16.31M | 19.46M | 21.24M |
| COGS % of Revenue | 0.3% | 0.38% | 0.38% | 0.34% | 0.31% | 0.33% |
| Gross Profit | 17.83M | 17.69M | 25.22M | 31.25M | 42.91M | 43.94M |
| Gross Margin % | 0.7% | 0.62% | 0.62% | 0.66% | 0.69% | 0.67% |
| Gross Profit Growth % | - | -0.01% | 0.43% | 0.24% | 0.37% | 0.02% |
| Operating Expenses | 50.12M | 55.08M | 96.71M | 119.08M | 117.74M | 110.5M |
| OpEx % of Revenue | 1.98% | 1.94% | 2.39% | 2.5% | 1.89% | 1.7% |
| Selling, General & Admin | 35.08M | 36.4M | 70.24M | 84.08M | 81.72M | 76.32M |
| SG&A % of Revenue | 1.38% | 1.28% | 1.74% | 1.77% | 1.31% | 1.17% |
| Research & Development | 15.02M | 18.59M | 26.58M | 35.37M | 36.97M | 34.37M |
| R&D % of Revenue | 0.59% | 0.65% | 0.66% | 0.74% | 0.59% | 0.53% |
| Other Operating Expenses | 16K | 93K | -108K | -377K | -954K | -183K |
| Operating Income | -32.29M | -37.39M | -71.49M | -87.82M | -74.83M | -66.57M |
| Operating Margin % | -1.27% | -1.32% | -1.77% | -1.85% | -1.2% | -1.02% |
| Operating Income Growth % | - | -0.16% | -0.91% | -0.23% | 0.15% | 0.11% |
| EBITDA | -30.37M | -35M | -67.88M | -82.25M | -66.49M | -57.97M |
| EBITDA Margin % | -1.2% | -1.23% | -1.68% | -1.73% | -1.07% | -0.89% |
| EBITDA Growth % | - | -0.15% | -0.94% | -0.21% | 0.19% | 0.13% |
| D&A (Non-Cash Add-back) | 1.91M | 2.39M | 3.61M | 5.57M | 8.34M | 8.6M |
| EBIT | -32.65M | -40.38M | -72.85M | -86.95M | -77.91M | -59.36M |
| Net Interest Income | -890K | -744K | -638K | 685K | 3.96M | 1.45M |
| Interest Income | 86K | 96K | 20K | 1.32M | 4.55M | 3.36M |
| Interest Expense | 976K | 840K | 658K | 639K | 588K | 1.91M |
| Other Income/Expense | -1.34M | -3.84M | -2.02M | 238K | -3.67M | 5.3M |
| Pretax Income | -33.63M | -41.23M | -73.51M | -87.58M | -78.5M | -61.27M |
| Pretax Margin % | -1.33% | -1.45% | -1.82% | -1.84% | -1.26% | -0.94% |
| Income Tax | 162K | -1.89M | 168K | -136K | 486K | 1.22M |
| Effective Tax Rate % | 1% | 0.95% | 1% | 1% | 1.01% | 1.02% |
| Net Income | -33.79M | -39.34M | -73.67M | -87.45M | -78.98M | -62.49M |
| Net Margin % | -1.33% | -1.39% | -1.82% | -1.84% | -1.27% | -0.96% |
| Net Income Growth % | - | -0.16% | -0.87% | -0.19% | 0.1% | 0.21% |
| Net Income (Continuing) | -33.79M | -39.34M | -73.67M | -87.45M | -78.98M | -62.49M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.53 | -0.82 | -1.33 | -1.36 | -1.22 | -0.95 |
| EPS Growth % | - | -0.55% | -0.62% | -0.02% | 0.1% | 0.22% |
| EPS (Basic) | -0.53 | -0.82 | -1.33 | -1.36 | -1.22 | -0.95 |
| Diluted Shares Outstanding | 63.86M | 48.02M | 55.3M | 64.1M | 64.75M | 65.78M |
| Basic Shares Outstanding | 63.86M | 48.02M | 55.3M | 64.1M | 64.75M | 65.78M |
| Dividend Payout Ratio | - | - | - | - | - | - |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 33.76M | 109.69M | 282.86M | 196.25M | 148.05M | 99.41M |
| Cash & Short-Term Investments | 18.43M | 97.34M | 265.32M | 178.61M | 123.25M | 80.23M |
| Cash Only | 18.07M | 74.63M | 192.96M | 161.31M | 123.25M | 80.23M |
| Short-Term Investments | 366K | 22.72M | 72.36M | 17.31M | 0 | 0 |
| Accounts Receivable | 9.71M | 7.85M | 7.09M | 8.05M | 15.21M | 8.69M |
| Days Sales Outstanding | 139.67 | 100.94 | 63.97 | 61.8 | 88.98 | 48.67 |
| Inventory | 3.61M | 3.38M | 5.73M | 5.16M | 6.48M | 5.87M |
| Days Inventory Outstanding | 174.94 | 115.34 | 137.31 | 115.41 | 121.59 | 100.86 |
| Other Current Assets | 339K | 27K | 775K | 731K | 345K | 835K |
| Total Non-Current Assets | 17.9M | 22.42M | 37.32M | 47.58M | 58.11M | 55.9M |
| Property, Plant & Equipment | 6.45M | 5.54M | 15.96M | 21.4M | 23.1M | 19.38M |
| Fixed Asset Turnover | 3.93x | 5.13x | 2.54x | 2.22x | 2.70x | 3.36x |
| Goodwill | 7.83M | 8.6M | 8.3M | 8.19M | 9M | 8.34M |
| Intangible Assets | 2.4M | 4.68M | 7.38M | 11.78M | 18.19M | 20.66M |
| Long-Term Investments | 373K | 775K | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 839K | 711K | 3.7M | 4.28M | 6.1M | 5.76M |
| Total Assets | 51.66M | 132.12M | 320.17M | 243.84M | 206.16M | 155.31M |
| Asset Turnover | 0.49x | 0.21x | 0.13x | 0.20x | 0.30x | 0.42x |
| Asset Growth % | - | 1.56% | 1.42% | -0.24% | -0.15% | -0.25% |
| Total Current Liabilities | 19.26M | 21.59M | 28.6M | 26.81M | 35.62M | 26.8M |
| Accounts Payable | 1.73M | 1.28M | 2.34M | 2.17M | 2.26M | 1.93M |
| Days Payables Outstanding | 83.79 | 43.66 | 56.01 | 48.57 | 42.32 | 33.21 |
| Short-Term Debt | 2.23M | 2.87M | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 5.73M | 5.25M | 9.16M | 10.27M | 13.58M | 11.22M |
| Current Ratio | 1.75x | 5.08x | 9.89x | 7.32x | 4.16x | 3.71x |
| Quick Ratio | 1.57x | 4.92x | 9.69x | 7.13x | 3.97x | 3.49x |
| Cash Conversion Cycle | 230.82 | 172.62 | 145.26 | 128.64 | 168.25 | 116.32 |
| Total Non-Current Liabilities | 10.14M | 10.02M | 16.17M | 16.9M | 19.09M | 32.02M |
| Long-Term Debt | 1.61M | 457K | 0 | 0 | 0 | 13.24M |
| Capital Lease Obligations | 3.66M | 2.88M | 11.25M | 14.05M | 15.67M | 14.6M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 4.79M | 6.54M | 4.92M | 2.85M | 3.42M | 4.18M |
| Total Liabilities | 29.4M | 31.61M | 44.77M | 43.71M | 54.71M | 58.82M |
| Total Debt | 8.46M | 7.25M | 13.06M | 16.74M | 18.6M | 30.03M |
| Net Debt | -9.61M | -67.38M | -179.9M | -144.56M | -104.65M | -50.2M |
| Debt / Equity | 0.38x | 0.07x | 0.05x | 0.08x | 0.12x | 0.31x |
| Debt / EBITDA | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - |
| Interest Coverage | -33.08x | -44.51x | -108.65x | -137.44x | -127.26x | -34.80x |
| Total Equity | 22.25M | 100.51M | 275.4M | 200.13M | 151.44M | 96.49M |
| Equity Growth % | - | 3.52% | 1.74% | -0.27% | -0.24% | -0.36% |
| Book Value per Share | 0.35 | 2.09 | 4.98 | 3.12 | 2.34 | 1.47 |
| Total Shareholders' Equity | 22.25M | 100.51M | 275.4M | 200.13M | 151.44M | 96.49M |
| Common Stock | 1.95M | 2.46M | 3.33M | 3.46M | 4.05M | 4.19M |
| Retained Earnings | -98.34M | -137.68M | -211.35M | -298.8M | -377.78M | -440.28M |
| Treasury Stock | 0 | 0 | 0 | -117K | -646K | -702K |
| Accumulated OCI | -581K | 8.3M | 12.54M | 23.96M | 53.98M | 61.04M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | -31.68M | -31.73M | -57.94M | -70.09M | -48.58M | -42.82M |
| Operating CF Margin % | -1.25% | -1.12% | -1.43% | -1.47% | -0.78% | -0.66% |
| Operating CF Growth % | - | -0% | -0.83% | -0.21% | 0.31% | 0.12% |
| Net Income | -33.63M | -41.23M | -73.51M | -87.58M | -78.5M | -61.27M |
| Depreciation & Amortization | 1.91M | 2.39M | 3.61M | 5.57M | 8.34M | 8.6M |
| Stock-Based Compensation | 717K | 1.36M | 8.51M | 13.61M | 15.24M | 16.49M |
| Deferred Taxes | -447K | -763K | -1.6M | -1.29M | -1.13M | -726K |
| Other Non-Cash Items | 1.39M | 2.69M | -1.08M | 873K | 6.6M | -3.33M |
| Working Capital Changes | -1.62M | 3.82M | 6.12M | -1.27M | 872K | -2.58M |
| Change in Receivables | -4.35M | 1.12M | 1.81M | 1.33M | -6.5M | 5.89M |
| Change in Inventory | -862K | 536K | -2.34M | -200K | -874K | 69K |
| Change in Payables | 5.6M | -185K | 8.98M | -1.43M | 6.87M | -7.38M |
| Cash from Investing | -3.03M | -24.32M | -56.93M | 41.97M | 8.32M | -8.18M |
| Capital Expenditures | -1.35M | -450K | -6.67M | -4.1M | -1.49M | -244K |
| CapEx % of Revenue | 0.05% | 0.02% | 0.16% | 0.09% | 0.02% | 0% |
| Acquisitions | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - |
| Other Investing | -1.68M | -2.75M | -3.99M | -6.28M | -7.73M | -7.93M |
| Cash from Financing | -1.02M | 107.05M | 237.77M | -1.57M | -2.82M | 11.59M |
| Debt Issued (Net) | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - |
| Other Financing | 1.76M | 1.07M | 10.55M | 748K | 226K | 0 |
| Net Change in Cash | - | - | - | - | - | - |
| Free Cash Flow | -34.71M | -34.93M | -64.61M | -80.47M | -57.8M | -51M |
| FCF Margin % | -1.37% | -1.23% | -1.6% | -1.69% | -0.93% | -0.78% |
| FCF Growth % | - | -0.01% | -0.85% | -0.25% | 0.28% | 0.12% |
| FCF per Share | -0.54 | -0.73 | -1.17 | -1.26 | -0.89 | -0.78 |
| FCF Conversion (FCF/Net Income) | 0.94x | 0.81x | 0.79x | 0.80x | 0.62x | 0.69x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -151.85% | -64.09% | -39.2% | -36.78% | -44.93% | -50.41% |
| Return on Invested Capital (ROIC) | -191.46% | -122.49% | -83.37% | -87.2% | -109.65% | -107.27% |
| Gross Margin | 70.3% | 62.29% | 62.35% | 65.71% | 68.8% | 67.42% |
| Net Margin | -133.23% | -138.52% | -182.14% | -183.87% | -126.63% | -95.89% |
| Debt / Equity | 0.38x | 0.07x | 0.05x | 0.08x | 0.12x | 0.31x |
| Interest Coverage | -33.08x | -44.51x | -108.65x | -137.44x | -127.26x | -34.80x |
| FCF Conversion | 0.94x | 0.81x | 0.79x | 0.80x | 0.62x | 0.69x |
| Revenue Growth | - | 11.98% | 42.43% | 17.58% | 31.14% | 4.49% |
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Europe, The Middle East And Africa | - | 34.88M | 43.96M | 46.93M |
| Europe, The Middle East And Africa Growth | - | - | 26.03% | 6.76% |
| North America | - | 6.73M | 10.73M | 11.3M |
| North America Growth | - | - | 59.33% | 5.35% |
| FRANCE | 7.41M | - | 10.08M | 10.33M |
| FRANCE Growth | - | - | - | 2.55% |
| ITALY | 6.12M | - | 8.55M | 9.98M |
| ITALY Growth | - | - | - | 16.71% |
| UNITED STATES | 3.94M | - | 9.46M | 9.32M |
| UNITED STATES Growth | - | - | - | -1.50% |
| SPAIN | 3.77M | - | 6.51M | 5.79M |
| SPAIN Growth | - | - | - | -11.12% |
| Asia Pacific | - | 2.95M | 3.7M | 4.05M |
| Asia Pacific Growth | - | - | 25.45% | 9.66% |
| Latin America | - | 3M | 3.99M | 2.89M |
| Latin America Growth | - | - | 32.87% | -27.57% |
| SWITZERLAND | 1.39M | - | 1.43M | 1.49M |
| SWITZERLAND Growth | - | - | - | 4.33% |
| Other Country | 8.9M | - | - | - |
| Other Country Growth | - | - | - | - |
| TURKEY | 2.68M | - | - | - |
| TURKEY Growth | - | - | - | - |
| AUSTRIA | 1.83M | - | - | - |
| AUSTRIA Growth | - | - | - | - |
| BRAZIL | 1.62M | - | - | - |
| BRAZIL Growth | - | - | - | - |
| GERMANY | 1.28M | - | - | - |
| GERMANY Growth | - | - | - | - |
SOPHiA GENETICS S.A. (SOPH) reported $73.3M in revenue for fiscal year 2024. This represents a 189% increase from $25.4M in 2019.
SOPHiA GENETICS S.A. (SOPH) grew revenue by 4.5% over the past year. Growth has been modest.
SOPHiA GENETICS S.A. (SOPH) reported a net loss of $75.0M for fiscal year 2024.
SOPHiA GENETICS S.A. (SOPH) has a return on equity (ROE) of -50.4%. Negative ROE indicates the company is unprofitable.
SOPHiA GENETICS S.A. (SOPH) had negative free cash flow of $43.9M in fiscal year 2024, likely due to heavy capital investments.